Filtered By:
Condition: Diabetes Mellitus
Education: Study
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 4396 results found since Jan 2013.
Doppler flow morphology characteristics of epiaortic arteries in aortic valve pathologies: a retrospective study on a cohort of patients with ischemic stroke
ConclusionsWell defined, qualitative Doppler flow characteristics detectable in the CCA and ICA are highly predictive for aortic valve disease. The consideration of these flow characteristics can be useful to streamline diagnostic and therapeutic measures, especially in the outpatient setting.
Source: Critical Ultrasound Journal - June 7, 2023 Category: Radiology Source Type: research
Endocan is Related to Increased Cardiovascular Risk in Type 2 Diabetes Mellitus Patients
Conclusion: Endocan was the independent predictor for moderate and high estimated risks (i.e., nonfatal and fatal CHD and nonfatal stroke risk scores) in T2D patients. When included in models with sex and obesity indices endocan demonstrated good clinical accuracy in discriminating T2D patients with high risk for nonfatal and fatal eCHD and nonfatal stroke risk from those patients with low risk.PMID:37279462 | DOI:10.1089/met.2023.0050
Source: Atherosclerosis - June 6, 2023 Category: Cardiology Authors: Aleksandra Klisic Jelena Kotur-Stevuljevic Ana Ninic Source Type: research
Association of bone turnover biomarkers with severe intracranial and extracranial artery stenosis in type 2 diabetes mellitus patients
CONCLUSION: BTM levels were found to be independent risk factors for severe intracranial and extracranial artery stenosis and were differentially associated with glucose and lipid metabolism in patients with T2DM. Therefore, BTMs may be promising biomarkers and potential therapeutic targets for artery stenosis.PMID:37273245 | PMC:PMC10236991 | DOI:10.4239/wjd.v14.i5.594
Source: Atherosclerosis - June 5, 2023 Category: Cardiology Authors: Si-Cong Si Wei Yang Hong-Yu Luo Yi-Xin Ma Huan Zhao Jia Liu Source Type: research
CO4 Outcomes of Non –Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials and Observational Studies
This study aimed to ident ify differences between original studies of NOACs vs warfarin to support interpretation of results across studies.
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: R. Wang, H. Lien, A. Borrow, D. Fleishman Source Type: research
Association of serum YKL-40 change with prognosis in acute ischemic stroke patients complicated with diabetes mellitus
Conclusion: Serum YKL-40 has a prognostic effect on the management of AIS patients with DM.PMID:37256280 | DOI:10.2217/bmm-2023-0108
Source: Future Medicine: Biomarkers in Medicine - May 31, 2023 Category: Internal Medicine Authors: Guang Hao Jian Sun Tingting Zhong Qian Xue Yu'an Zou Source Type: research
Differential and sex- and age-specific risks of cardiometabolic diseases with unrelated metabolic syndrome dimensions
CONCLUSIONS: MetS can be dissected into two distinct presentations characterized by differential sex- and age-associated cardiometabolic disease risk, confirming the loss of information using the dichotomous MetS.PMID:37254031 | DOI:10.1002/oby.23778
Source: Obesity - May 30, 2023 Category: Eating Disorders & Weight Management Authors: Linjun Ao Ko Willems van Dijk Diana van Heemst Raymond Noordam Source Type: research
Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong
ConclusionsBased on real-world data of type 2 diabetic patients in Hong Kong, SGLT2I use was associated with lower risk of incident AF, stroke/transient ischemic attack, and cardiovascular and all-cause mortality outcomes compared to DPP4I use.
Source: Cardiovascular Drugs and Therapy - May 29, 2023 Category: Cardiology Source Type: research
Hydroxychloroquine exposure reduces the risk of cardiovasular disease events in patients with hypertension or diabetes mellitus
CONCLUSIONS: HCQ has protective effect on CVD events, including both AMI and ischaemic stroke in the patients with traditional risk factors. The protective effect of HCQ on CVD events is prominent in older patients.PMID:37246776 | DOI:10.55563/clinexprheumatol/y7psev
Source: Clinical and Experimental Rheumatology - May 29, 2023 Category: Rheumatology Authors: Chun-Hsiung Chen Hung-An Chen Hsien-Tzung Liao Chen-Hung Chen Source Type: research
